- Lobbying
- Cookab AND Hashemi
Lobbying Arrangements Results for 'Cookab Hashemi'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Precision Medicine Answers for Kids Today Act HELP Co-Pays Act - H.R. 830/S.1375 Newborn screening reauthorization Medicaid Drug Rebate Program (MDRP) rule Inflation Reduction Act - Orphan Drugs ... |
Ultragenyx
|
HASHEMI STRATEGIC ADVISORS | |||
Details General Healthcare and FDA issues |
Abbott Laboratories
|
FEDERAL HEALTH POLICY STRATEGIES | |||
Details Issues related to S. 1976/H.R. 4014 Preserving Patient Access to Home Infusion Act of 2023 |
Option Care
|
FEDERAL HEALTH POLICY STRATEGIES | |||
Details Review Choice Demonstration for Inpatient Rehabilitation Facilities (CMS-10765), Medicare payment policies and access to inpatient rehabilitation facility care generally |
Scully Roskey and Missmar on behalf of Encompass Health
|
FEDERAL HEALTH POLICY STRATEGIES | |||
Details General healthcare and FDA issues |
Abbott Laboratories
|
Lincoln Policy Group | |||
Details Medicare issues Healthcare issues Supply chain issues |
Elekta, Inc.
Medical Device manufacturer |
in-house lobbying | |||
Details Issues related to COVID; General issues related to Medicare and Medicaid; issues related to commercial insurance |
UPMC Health Plan
|
Lincoln Policy Group | |||
Details Modernizing Opioid Treatment Access Act (S. 1359/H.R. 644) |
Medication Assisted Treatment Leadership Council
|
FEDERAL HEALTH POLICY STRATEGIES | |||
Details Implementation of the drug pricing provisions in the Inflation Reduction Act Access to Prescription Digital Therapeutics Act (H.R. 1458) |
Pfizer
|
FEDERAL HEALTH POLICY STRATEGIES | |||
Details General healthcare issues General issues related to Medicaid and Medicare Private Insurance COVID relief proposals |
Alliance of Community Health Plans
|
Lincoln Policy Group | |||
Details Medical billing issues Medicare legislative and regulatory issues S.1895 - Lower Health Care Costs Act COVID relief proposals Issues related to No Surprises Act implementation |
UPMC
|
Lincoln Policy Group | |||
Details H.R. 4911, Medicare Advantage Quality Payment Relief Act S. 150/H.R. 2166 Ensuring Parity in MA and PACE for Audio-Only Telehealth Act of 2021 S. 2411/ H.R. 533 Stop COVID-19 Test Surprise Medical ... |
Alliance of Community Health Plans
|
FEDERAL HEALTH POLICY STRATEGIES | |||
Details Issues related to CMS final rules governing Outpatient Protective Payment Systems (OPPS), Physician Fee Schedule (PFS) and 340B remedies; issues related to hospital transparency and health care con... |
UPMC
|
FEDERAL HEALTH POLICY STRATEGIES | |||
Details Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistan... |
Pfizer
|
Lincoln Policy Group | |||
Details CY 2022 End-Stage Renal Disease (ESRD) Prospective Payment System Proposed Rule COVID relief proposals Issues relating to Medicare Advantage proposed dialysis access policies |
Fresenius Medical Care North America
|
Lincoln Policy Group | |||
Details Issues related to the Pandemic and All Hazards Preparedness Act (PAHPA) reauthorization; Next Generation COVID-19 vaccines and boosters; Issues related to Accelerated Approval reforms and accelerat... |
INOVIO PHARMACEUTICALS, INC.
|
in-house lobbying | |||
Details H.R. 5027, Chronic Kidney Disease Improvement in Research and Training Act; CMS 1782, CY 2024 Changes to the End-Stage Renal Disease (ESRD) Prospective Payment Systems (PPS) and Quality Incentive P... |
Fresenius Medical Care North America
|
FEDERAL HEALTH POLICY STRATEGIES | |||
Details CY 2020 Medicare Home Health Prospective Payment System (PPS) rule and the Patient-Driven Groupings Model COVID relief proposals H.R. 2455, The Resetting the Improving Medicare Post-Acute Transform... |
Scully Roskey and Missmar on behalf of Encompass Health
|
Lincoln Policy Group | |||
Details appropriations child care child protection appropriations water safety chronic disease prevention charitable giving |
YMCA OF THE USA
|
in-house lobbying | |||
Details International trade and protection of intellectual property; TRIPS Waiver; the Medical Supply Chain Resiliency Act; compulsory licensing and other IP issues in multiple countries. Advocate on drug ... |
GILEAD SCIENCES, INC.
|
in-house lobbying |